Summary:
A long-term, open-label safety study of HC-CR capsules with flexible dosing to treat subjects with moderate to severe chronic pain.
Qualified Participants Must:
• Be between 18-75 years of age
•
Have a diagnosed moderate to severe chronic pain condition for past 3 months
•
Qualify for around the clock treatment of their pain
•
Have been taking opioids for at least 5days/week for the past month
•
Be able to speak, read, write, and understand English
Qualified Participants May Receive:
All study-related visits and testing done free of charge. Compensation for time and travel may be available.